IN8bio, Inc.INABNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-15.3%
5Y CAGR+15.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-15.3%/yr
vs +94.2%/yr prior
5Y CAGR
+15.2%/yr
Recent deceleration
Acceleration
-109.5pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $17.36M | -43.0% |
| 2024 | $30.44M | +9.3% |
| 2023 | $27.84M | -2.4% |
| 2022 | $28.52M | +94.6% |
| 2021 | $14.65M | +71.2% |
| 2020 | $8.56M | +68.9% |
| 2019 | $5.07M | +152.8% |
| 2018 | $2.00M | - |